China Biologic Produ
(CBPO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 53,426 | 34,510 | 14,816 | 18,824 | 15,774 |
| Depreciation Amortization | 6,038 | 3,895 | 1,849 | 6,416 | 4,969 |
| Income taxes - deferred | -583 | -312 | 90 | -1,553 | N/A |
| Accounts receivable | -4,470 | -3,868 | -2,045 | -1,510 | -928 |
| Accounts payable and accrued liabilities | 10 | -447 | -181 | -59 | -150 |
| Other Working Capital | -18,138 | -13,333 | -11,238 | -2,289 | -1,152 |
| Other Operating Activity | -4,986 | -1,090 | -1,199 | 30,472 | 16,945 |
| Operating Cash Flow | $31,296 | $19,355 | $2,093 | $50,301 | $35,458 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,225 | -6,154 | -2,013 | -3,486 | -2,323 |
| Net Acquisitions | -4,026 | -4,022 | -1,476 | 1,573 | 1,571 |
| Purchase Of Investment | N/A | N/A | N/A | -3,225 | N/A |
| Purchase Sale Intangibles | -1,338 | -559 | -25 | -2,106 | -1,374 |
| Other Investing Activity | -1,338 | -559 | -25 | -1,722 | -5,307 |
| Investing Cash Flow | $-11,590 | $-10,736 | $-3,514 | $-6,861 | $-6,059 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 5,884 | 5,868 | 5,876 | 22,504 | 22,483 |
| Debt Repayment | N/A | N/A | N/A | -2,841 | -8,734 |
| Common Stock Issued | 689 | 689 | 689 | 4,000 | N/A |
| Dividend Paid | -8,629 | -4,864 | -4,781 | -2,969 | N/A |
| Other Financing Activity | -8,114 | -8,102 | -2,962 | -19,128 | -1,653 |
| Financing Cash Flow | $-10,170 | $-6,409 | $-1,178 | $1,565 | $12,096 |
| Exchange Rate Effect | 1,199 | 209 | -55 | 24 | 39 |
| Beginning Cash Position | 53,844 | 53,844 | 53,844 | 8,815 | 8,815 |
| End Cash Position | 64,579 | 56,263 | 51,190 | 53,844 | 50,348 |
| Net Cash Flow | $10,735 | $2,419 | $-2,654 | $45,029 | $41,534 |
| Free Cash Flow | |||||
| Operating Cash Flow | 31,296 | 19,355 | 2,093 | 50,301 | 35,458 |
| Capital Expenditure | -6,225 | -6,154 | -2,013 | -3,523 | -2,324 |
| Free Cash Flow | 25,071 | 13,201 | 80 | 46,778 | 33,134 |